A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Betagan Indications, Dosage, Storage, Stability - Levobunolol
Betagan Indications, Dosage, Storage, Stability - Levobunolol
INDICATIONS
BETAGAN has been shown to be effective in lowering intraocular
pressure and may be used in patients with chronic
open-angle glaucoma
or ocular hypertension.
DOSAGE AND ADMINISTRATION
The recommended starting dose
is one to two drops of BETAGAN 0.5% in the affected eye(s) once
a day. Typical dosing with BETAGAN 0.25% is one to two drops twice
daily. In patients with more
severe or uncontrolled glaucoma, BETAGAN 0.5% can be administered
b.i.d. As
with any new medication, careful monitoring of patients is advised.
Dosages above one drop
of BETAGAN 0.5% b.i.d.
are not generally more effective. If the patient’s IOP
is not at a satisfactory level on this regimen, concomitant
therapy with dipivefrin
and/or epinephrine, and/or pilocarpine and other miotics, and/or
systemically administered carbonic
anhydrase inhibitors,
such as acetazolamide,
can be instituted. Patients should not typically use two or more
topical ophthalmic beta-adrenergic
blocking agents simultaneously.
HOW SUPPLIED
BETAGAN (levobunolol HCI) Liquifilm sterile
ophthalmic solution,
is supplied in white opaque
plas-tic dropper bottles
as follows:
BETAGAN 0.25%
C Cap® Compliance Cap BID (twice daily)
- 5 mL - NDC 11980-469-25
- 10 mL - NDC 11980-469-20
BETAGAN 0.5%
Standard Cap
C Cap® Compliance Cap
CAUTION: Federal (USA) law
prohibits dispensing without prescription.
top
